Local infection of the skin and subcutaneous tissue, unspecified
ICD-10 L08.9 is a billable code used to indicate a diagnosis of local infection of the skin and subcutaneous tissue, unspecified.
L08.9 refers to local infections of the skin and subcutaneous tissue that are unspecified in nature. These infections can manifest as localized redness, swelling, warmth, and tenderness in the affected area, often accompanied by pus formation or systemic symptoms such as fever. The skin and subcutaneous tissue comprise the outermost layers of the body, serving as a barrier against pathogens. Infections can arise from various sources, including bacterial, viral, or fungal agents, and may occur following trauma, surgical procedures, or in the presence of underlying conditions such as diabetes or immunosuppression. Disease progression can vary, with some infections resolving spontaneously while others may lead to complications such as abscess formation or systemic spread. Diagnostic considerations include a thorough clinical examination, history taking, and, when necessary, laboratory tests such as cultures or imaging studies to assess the extent of the infection. Accurate diagnosis is crucial for effective management and to prevent potential complications.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L08.9 encompasses a range of local infections of the skin and subcutaneous tissue that do not have a specified cause. This includes infections such as cellulitis, abscesses, and localized skin infections that are not further classified.
L08.9 should be used when the infection is localized and unspecified, and when there is no clear indication of the causative organism or when more specific codes do not apply.
Documentation should include a detailed clinical assessment, description of symptoms, any relevant laboratory results, and a treatment plan that justifies the use of L08.9.
